Skip to content

Nasdaq · CIK 0001882782

ODTX Odyssey Therapeutics, Inc.

Insider trading from SEC Form 4. Last filing May 13, 2026. Close $18.26 on Oct 12, 2026, +17% from the 52-week low and -37% from the high.

In brief

Odyssey Therapeutics, Inc. (ODTX) has 15 SEC Form 4 filings on file from 15 insiders, the latest filed on May 13, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

8 open-market trades have been scored at ODTX. The newest: Tpg Gp A, LLC bought $25M of stock on May 11, 2026, filed May 13, 2026, scored 58 (moderate). 7 insiders bought within 14 days of each other around May 11, 2026.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company

Price and insider trades, last year

ODTXOct 12, 2026 · close 18.26

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Odyssey Therapeutics, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
58ModerateTpg Gp A, LLC
other
buy
$25M
1,388,889 shares
+60%-
61NotableDimension Capital II, L.P.
director
buy
$20M
1,111,111 shares
+50%-
50ModerateShelley Chu
director
buy
$200k
11,111 shares
--
53ModerateSr One Capital Management, LLC
owner
buy
$10.0M
555,555 shares
+35%-
17WeakSr One Capital Management, LLC
owner
sell
$32k
1,780 shares
-0%-
37WeakJason Haas
Chief Financial Officer
buy
$20k
1,000 shares
+2%-
40ModerateJeffrey M Leiden
director
buy
$100k
5,000 shares
+2%-
61NotableNan (LN) Li
director
buy
$20M
1,111,111 shares
+50%-

Transactions

The newest 50 of 79 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
May 11, 2026Tpg Gp A, LLC
other
JOther
Common Stockindirect: See Explanation of Responses
+423,111--423,111May 13, 2026
May 11, 2026Tpg Gp A, LLC
other
JOther
Common Stockindirect: See Explanation of Responses
-2,351$18.00$42k420,760May 13, 2026
May 11, 2026Tpg Gp A, LLC
other
CConversion
Common Stockindirect: See Explanation of Responses
+1,880,497--2,301,257May 13, 2026
May 11, 2026Tpg Gp A, LLC
other
POpen-market purchase
Common Stockindirect: See Explanation of Responses
+1,388,889$18.00$25M3,690,146May 13, 2026
May 11, 2026Tpg Gp A, LLC
other
JOther
Warrants (right to buy)derivativeindirect: See Explanation of Responses
-423,111--0May 13, 2026
May 11, 2026Tpg Gp A, LLC
other
CConversion
Series D Preferred Stockderivativeindirect: See Explanation of Responses
-18,272,789--0May 13, 2026
May 8, 2026Dimension Capital II, L.P.
director
CConversion
Common Stock
+1,709,543--2,222,405May 12, 2026
May 8, 2026Dimension Capital II, L.P.
director
POpen-market purchase
Common Stock
+1,111,111$18.00$20M3,333,516May 12, 2026
May 8, 2026Dimension Capital II, L.P.
director
CConversion
Series D Convertible Preferred Stockderivative
-16,611,626--0May 12, 2026
May 11, 2026Anthony W. Opipari
See Remarks
CConversion
Common Stock
+6,965--6,965May 11, 2026
May 7, 2026Collin M Todd
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+93,904$0.00$093,904May 11, 2026
May 7, 2026Ourania Tatsis
director
AGrant or award
Stock Option (Right to Buy)derivative
+27,393$0.00$027,393May 11, 2026
May 8, 2026Jeffrey M Leiden
director
POpen-market purchase
Common Stock
+5,000$20.00$100k270,198May 11, 2026
May 7, 2026Ian F Smith
director
AGrant or award
Stock Option (Right to Buy)derivative
+27,393$0.00$027,393May 11, 2026
May 7, 2026Valerie Odegard
director
AGrant or award
Stock Option (Right to Buy)derivative
+27,393$0.00$027,393May 11, 2026
May 11, 2026Gary D Glick
See Remarks
CConversion
Common Stock
+27,386--415,973May 11, 2026
May 11, 2026Nan (LN) Li
director
CConversion
Common Stockindirect: See footnote
+1,709,543--2,222,405May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
CConversion
Common Stockindirect: See Note 2
+474,048--474,048May 11, 2026
May 7, 2026Timothy P Walbert
director
AGrant or award
Stock Option (Right to Buy)derivative
+27,393$0.00$027,393May 11, 2026
May 7, 2026Natalie Dales
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+79,773$0.00$079,773May 11, 2026
May 8, 2026Jason Haas
Chief Financial Officer
POpen-market purchase
Common Stock
+1,000$20.00$20k62,908May 11, 2026
May 11, 2026Shelley Chu
director
POpen-market purchase
Common Stock
+11,111$18.00$200k11,111May 11, 2026
May 11, 2026Nan (LN) Li
director
POpen-market purchase
Common Stockindirect: See footnote
+1,111,111$18.00$20M3,333,516May 11, 2026
May 11, 2026Anthony W. Opipari
See Remarks
MOption exercise
Common Stock
+541--7,506May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
CConversion
Common Stockindirect: See Note 2
+139,366--613,414May 11, 2026
May 11, 2026Gary D Glick
See Remarks
CConversion
Series C Convertible Preferred Stockderivative
-100,000--0May 11, 2026
May 11, 2026Jeffrey M Leiden
director
CConversion
Common Stockindirect: See footnote
+28,698--28,698May 11, 2026
May 11, 2026Nan (LN) Li
director
CConversion
Series D Convertible Preferred Stockderivativeindirect: See footnote
-16,611,626--0May 11, 2026
May 11, 2026Anthony W. Opipari
See Remarks
FTax withholding
Common Stock
-4$18.00$727,502May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
CConversion
Common Stockindirect: See Note 2
+59,692--673,106May 11, 2026
May 11, 2026Gary D Glick
See Remarks
CConversion
Series D Convertible Preferred Stockderivative
-166,116--0May 11, 2026
May 11, 2026Jeffrey M Leiden
director
MOption exercise
Common Stockindirect: See footnote
+2,963--31,661May 11, 2026
May 11, 2026Jeffrey M Leiden
director
FTax withholding
Common Stockindirect: See footnote
-17$18.00$30631,644May 11, 2026
May 7, 2026Gary D Glick
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+884,450$0.00$0884,450May 11, 2026
May 11, 2026Anthony W. Opipari
See Remarks
CConversion
Series A Convertible Preferred Stockderivative
-18,531--0May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
CConversion
Common Stockindirect: See Note 2
+61,762--734,868May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
CConversion
Common Stockindirect: See Note 2
+683,817--1,418,685May 11, 2026
May 11, 2026Jeffrey M Leiden
director
CConversion
Series B Convertible Preferred Stockderivativeindirect: See footnote
-79,166--0May 11, 2026
May 11, 2026Anthony W. Opipari
See Remarks
CConversion
Series B Convertible Preferred Stockderivative
-11,083--0May 11, 2026
May 11, 2026Jeffrey M Leiden
director
CConversion
Series C Convertible Preferred Stockderivativeindirect: See footnote
-100,000--0May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
XIn-the-money exercise
Common Stockindirect: See Note 2
+191,541--1,610,226May 11, 2026
May 11, 2026Anthony W. Opipari
See Remarks
CConversion
Series C Convertible Preferred Stockderivative
-20,000--0May 11, 2026
May 11, 2026Jeffrey M Leiden
director
CConversion
Series D Convertible Preferred Stockderivativeindirect: See footnote
-96,002--0May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
SOpen-market sale
Common Stockindirect: See Note 2
-1,065$18.00$19k1,609,161May 11, 2026
May 11, 2026Anthony W. Opipari
See Remarks
CConversion
Series D Convertible Preferred Stockderivative
-17,545--0May 11, 2026
May 7, 2026Anthony W. Opipari
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+250,203$0.00$0250,203May 11, 2026
May 7, 2026Jeffrey M Leiden
director
AGrant or award
Stock Option (Right to Buy)derivative
+626,220$0.00$0626,220May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
POpen-market purchase
Common Stockindirect: See Note 2
+222,222$18.00$4.0M1,831,383May 11, 2026
May 11, 2026Sr One Capital Management, LLC
owner
CConversion
Common Stockindirect: See Note 9
+118,512--118,512May 11, 2026
May 7, 2026Anthony W. Opipari
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+27,777$0.00$027,777May 11, 2026
50 of 79 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about ODTX

Answered from the filings on this page, as of the latest one.

Are insiders buying ODTX?

No. In the last 90 days no insider at Odyssey Therapeutics, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade ODTX on the open market?

Tpg Gp A, LLC bought $25M of ODTX on May 11, 2026 and filed the Form 4 on May 13, 2026. InsiderTell scored 58 (moderate), with 7 insiders on the same side within 14 days.

How many insiders file Form 4 at Odyssey Therapeutics, Inc.?

15 people have filed a Form 4 at Odyssey Therapeutics, Inc., among them Shelley Chu (director), Natalie Dales (See Remarks), Dimension Capital II, L.P. (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ODTX insider trading: Odyssey Therapeutics, Inc. | InsiderTell